Associations Between APOE Genotypes and Vascular Pathology Lesions in Alzheimer's Disease: Insights from the NACC Dataset

Our findings suggest that carrying at least one APOE ɛ4 allele increases the risk of arteriolosclerosis and hippocampal sclerosis, while the presence of at least one APOE ɛ2 increased the risk of large arterial infarcts. TDP-43 proteinopathy modifies these effects, with APOE ε4 showing stronger vascular and neurodegenerative associations in those with absent TDP-43 proteinopathy but not in those with TDP-43 proteinopathy.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70855_107130
Primary Topic
Alzheimer's disease research and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Associations Between APOE Genotypes and Vascular Pathology Lesions in Alzheimer's Disease: Insights from the NACC Dataset

Alfred K. Njamnshi, Yannick N. Wadop, Xueqiu Jian, Bernard Fongang et al.
Alzheimer s & Dementia
Alzheimer's disease research and treatments
article

Associations Between APOE Genotypes and Vascular Pathology Lesions in Alzheimer's Disease: Insights from the NACC Dataset

Alfred K. Njamnshi, Yannick N. Wadop, Xueqiu Jian, Bernard Fongang, José E Cavazos, Habil Zare, Apochi Obed Okwoli, Biniyam Ayele, Rebecca Bernal, Jayandra J. Himali, Alice Nono Djotsa, Alfred N. Fonteh, the STAC ‐ African Initiative on Bioinformatics Online Training in Neurodegenerative Diseases (AI‐BOND), Sudha Seshadri, Margaret E Flanagan, Crystal Wiedner, Agustin Ruiz, Nkouonlack Cyrille, Muralidharan Sargurupremraj
article en

Abstract

Our findings suggest that carrying at least one APOE ɛ4 allele increases the risk of arteriolosclerosis and hippocampal sclerosis, while the presence of at least one APOE ɛ2 increased the risk of large arterial infarcts. TDP-43 proteinopathy modifies these effects, with APOE ε4 showing stronger vascular and neurodegenerative associations in those with absent TDP-43 proteinopathy but not in those with TDP-43 proteinopathy.

Alzheimer s & DementiaVol. 21(S1)
Boston University (US), Huntington Medical Research Institutes (US), Michael E. DeBakey VA Medical Center (US), Université de Yaoundé I (CM), National Forensic Sciences University (IN), Texas A&M University – San Antonio (US), University of Miami (US), The University of Texas at San Antonio Health Science Center (US), Baylor College of Medicine (US), Universitat Internacional de Catalunya (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), Urology San Antonio (US), Institute for Neurodegenerative Disorders (US), Framingham Heart Study (US), Dr. John T. Macdonald Foundation (US), Catholic University of Central Africa (CM), Global Brain Health Institute (US), Addis Ababa University (ET), The University of Texas at San Antonio (US), The University of Texas Health Science Center at Houston (US)
Quality Education
Openalex Percentile: Top 33%
Alzheimer's disease research and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.